James Sapirstein - Net Worth and Insider Trading
James Sapirstein Net Worth
The estimated net worth of James Sapirstein is at least $112,087 dollars as of 2024-04-25. James Sapirstein is the Chairman and CEO of First Wave BioPharma Inc and owns about 37,105 shares of First Wave BioPharma Inc (FWBI) stock worth over $112,057. James Sapirstein is also the CEO of Hepion Pharmaceuticals Inc and owns about 23 shares of Hepion Pharmaceuticals Inc (HEPA) stock worth over $30. Details can be seen in James Sapirstein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James Sapirstein has not made any transactions after 2024-04-01 and currently still holds the listed stock(s).
Transaction Summary of James Sapirstein
James Sapirstein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Sapirstein owns 11 companies in total, including First Wave BioPharma Inc (FWBI) , Renovaro Inc (RENB) , and Marizyme Inc (MRZM) among others .
Click here to see the complete history of James Sapirstein’s form 4 insider trades.
Insider Ownership Summary of James Sapirstein
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
FWBI | First Wave BioPharma Inc | 2024-04-01 | director & President and CEO |
RENB | Renovaro Inc | 2018-03-06 | director |
MRZM | Marizyme Inc | 2018-12-06 | director & Interim Chief Executive Office & other: Executive Chairman |
HEPA | Hepion Pharmaceuticals Inc | 2016-02-18 | director & Chief Executive Officer |
RSPI | RespireRx Pharmaceuticals Inc | 2014-09-03 | director |
PBYA | Upstryve Inc | 2015-07-06 | director |
ADYX | Adynxx Inc | 2014-01-09 | CEO & Therapeutics Division |
ONCO | Onconetix Inc | 2022-02-23 | director |
CRXTQ | Clarus Therapeutics Holdings Inc | 2020-12-15 | director |
ZVSA | ZyVersa Therapeutics Inc | 2023-01-05 | director |
BLUWU | Blue Water Acquisition Corp | 2020-12-15 | director |
James Sapirstein Latest Holdings Summary
James Sapirstein currently owns a total of 2 stocks. Among these stocks, James Sapirstein owns 37,105 shares of First Wave BioPharma Inc (FWBI) as of April 1, 2024, with a value of $112,057 and a weighting of 99.97%. James Sapirstein also owns 23 shares of Hepion Pharmaceuticals Inc (HEPA) as of February 18, 2016, with a value of $30 and a weighting of 0.03%.
Latest Holdings of James Sapirstein
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
FWBI | First Wave BioPharma Inc | 2024-04-01 | 37,105 | 3.02 | 112,057 |
HEPA | Hepion Pharmaceuticals Inc | 2016-02-18 | 23 | 1.32 | 30 |
Holding Weightings of James Sapirstein
James Sapirstein Form 4 Trading Tracker
According to the SEC Form 4 filings, James Sapirstein has made a total of 5 transactions in First Wave BioPharma Inc (FWBI) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in First Wave BioPharma Inc is the sale of 174 shares on April 1, 2024, which brought James Sapirstein around $736.
According to the SEC Form 4 filings, James Sapirstein has made a total of 0 transactions in Hepion Pharmaceuticals Inc (HEPA) over the past 5 years. The most-recent trade in Hepion Pharmaceuticals Inc is the acquisition of 18 shares on February 18, 2016, which cost James Sapirstein around $10,000.
Insider Trading History of James Sapirstein
- 1
James Sapirstein Trading Performance
GuruFocus tracks the stock performance after each of James Sapirstein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Sapirstein is -42.85%. GuruFocus also compares James Sapirstein's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Sapirstein within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James Sapirstein's insider trading performs compared to the benchmark.
Performance of James Sapirstein
Average Return
19.6%
Outperforming Transactions
67%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | -8.89 | -42.85 | -31.97 | 19.6 | -50.23 | -68.79 |
Relative Return to S&P 500(%) | -10.55 | -40.83 | -36.34 | 8.29 | -64.81 | -79.14 |
James Sapirstein Ownership Network
Ownership Network List of James Sapirstein
Ownership Network Relation of James Sapirstein
James Sapirstein Owned Company Details
What does First Wave BioPharma Inc do?
Who are the key executives at First Wave BioPharma Inc?
James Sapirstein is the director & President and CEO of First Wave BioPharma Inc. Other key executives at First Wave BioPharma Inc include Chief Financial Officer Sarah Romano , CHIEF FINANCIAL OFFICER Daniel H Schneiderman , and CHIEF MEDICAL OFFICER James Pennington .
First Wave BioPharma Inc (FWBI) Insider Trades Summary
Over the past 18 months, James Sapirstein made 5 insider transaction in First Wave BioPharma Inc (FWBI) with a net sale of 8,338. Other recent insider transactions involving First Wave BioPharma Inc (FWBI) include a net sale of 4,944 shares made by Sarah Romano , a net sale of 6,063 shares made by Charles J Casamento ,
In summary, during the past 3 months, insiders sold 3,256 shares of First Wave BioPharma Inc (FWBI) in total and bought 0 shares, with a net sale of 3,256 shares. During the past 18 months, 4,311 shares of First Wave BioPharma Inc (FWBI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,311 shares.
First Wave BioPharma Inc (FWBI)'s detailed insider trading history can be found in Insider Trading Tracker table.
First Wave BioPharma Inc Insider Transactions
James Sapirstein Mailing Address
Above is the net worth, insider trading, and ownership report for James Sapirstein. You might contact James Sapirstein via mailing address: 1517 San Jacinto, Houston Tx 77002.